Growing Demand from Pharma & Healthcare Sectors Will Strengthen the Aseptic Packaging Market in Americas by 2019
Heightened demand from the pharma and healthcare sectors is driving growth in the Aseptic Packaging Market in Americas, which is expected to grow at a CAGR of 9.37% from 2014 to 2019, says research firm TechNavio.
About the Report
Ensuring the safety of drugs before they are administered to patients has become one of the key concerns for health care providers. Adoption of the aseptic filling process guarantees an elongated shelf life for drugs at a much lower cost.
“The majority of demand for aseptic packaging from the pharmaceutical and healthcare sectors stems from the US, which alone accounted for more than 30% of the global market in 2014,” says Faisal Ghaus, Vice President of TechNavio.
Key Information Covered in the Report:
• Market segmentation, size and forecast through 2019
• Market Growth Drivers:
• Increased Focus on Product Innovation
• Market Challenges:
• Increased Concern over Contamination in Aseptic Packaging
• Market Trends:
• Adoption of Electrical Sterilization Methods for Solid Food Products
• Key Vendors:
• Amcor Ltd.
• Bemis Company Inc.
• Sealed Air Corp.
• Other Prominent Vendors:
• Aseptic Solutions USA
• CDF
• DS Smith
• Goglio
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
.png)
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
.png)
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
.png)
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
.png)
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance